🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementDay 3 on sema and I feel like death warmed over

Day 3 on sema and I feel like death warmed over

jason_sac26 Sat, Mar 28, 2026 at 9:36 PM 7 replies 741 viewsPage 1 of 2
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Mar 28, 2026 at 9:36 PM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

What I am trying to establish is what distinguishes the nausea you can titrate through from the nausea that means stop.

Happy to be told the question itself is wrong.

38 8pete_RVA, CarlaRPh_TPA, steph_laguna and 35 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Mar 28, 2026 at 11:51 PM#2

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

37 7raj_cambridge, ingrid_STO, pete_nash and 34 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Mar 29, 2026 at 2:06 AM#3
NurseKim_ATL said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

No disagreement with NurseKim_ATL. One condition attached. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Correct me if the detail matters more than I have assumed.

Last edited: Mar 29, 2026 at 4:06 AM
36 6DoseLogDan, SleepFixSam, PurityPaulOR and 33 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Mar 29, 2026 at 4:22 AM#4
jason_sac26 said:
The nausea I get is not really nausea, it is an aversion.

Same position here, arrived at the long way round. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

I would rather be corrected than agreed with, if it comes to it.

35 5LindaRN_retired, tommy_boulder, hyun_seoul and 32 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Mar 29, 2026 at 5:51 PM#5

Clinical perspective, offered as context rather than as advice. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

34 4Dr.EndoIndy, tom_AK, josh_phd_bmore and 31 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register